Virtus LifeSci Biotech Pr... (BBP)
AMEX: BBP
· Real-Time Price · USD
66.86
-0.00 (-0.00%)
At close: Aug 21, 2025, 9:46 AM
-0.00% (1D)
| Bid | 66.71 |
| Market Cap | 24.7M |
| AUM | 26.68M |
| NAV | 66.7 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 369.47K |
| Inception Date | Dec 16, 2014 |
| Ask | 67.52 |
| Volume | 381 |
| Open | 67.33 |
| Previous Close | 66.86 |
| Day's Range | 66.86 - 67.33 |
| 52-Week Range | 48.65 - 69.12 |
| Holdings | 198 |
| Expense Ratio | 0.79% |
About BBP
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.
Asset Class Equity | Specialty
Ticker Symbol BBP
Inception Date Dec 16, 2014
Provider Virtus Investment Partners
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 23.43% of assets
| Name | Symbol | Weight |
|---|---|---|
| Ardelyx, Inc. | ARDX | 2.62% |
| Rhythm Pharmaceutica... | RYTM | 2.56% |
| Alnylam Pharmaceutic... | ALNY | 2.50% |
| Aurinia Pharmaceutic... | AUPH | 2.43% |
| Apellis Pharmaceutic... | APLS | 2.30% |
| Ligand Pharmaceutica... | LGND | 2.24% |
| Novavax, Inc. | NVAX | 2.21% |
| Mirum Pharmaceutical... | MIRM | 2.21% |
| Insmed Incorporated | INSM | 2.18% |
| Crispr Therapeutics ... | CRSP | 2.18% |
Dividends Dividend Yield 0.18%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 20, 2017 | $0.0723 | Dec 27, 2017 |
| Dec 21, 2015 | $0.3970 | Dec 29, 2015 |
